Occam Places CBO at A-Alpha Bio
In September 2025, Occam Global, a leader in executive recruiting for TechBio, placed Troy Lionberger, PhD, as CBO of A-Alpha Bio.
Lionberger is a proven platform strategist and dealmaker with over a decade of experience in forming high-value partnerships across various markets, including pharmaceuticals, agriculture, and industrial biotechnology. Before joining A-Alpha, he served as the CBO at Abbratech and spent nearly ten years at Berkeley Lights, where he held R&D and business development roles. He led commercial initiatives that secured more than $200M in signed deals, including partnerships with Ginkgo Bioworks, Thermo Fisher Scientific, and Bayer Crop Science. His cross-functional expertise also helped steer the company through its IPO and its eventual acquisition by Bruker Corporation.
Lionberger earned two undergraduate degrees from UC Berkeley in Molecular and Cell Biology and Bioengineering, as well as a Master's in Mechanical Engineering and a PhD in Cellular and Molecular Biology from the University of Michigan.
Occam Global is an international life science executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, techbio, life sciences, and venture capital sectors. Our firm’s unique strength lies in our seamless access to elite talent, proven expertise in aligning exceptional business and scientific leaders with optimal opportunities, and a steadfast dedication to creating meaningful industry impact, guided by elevated ethics and enlightened aggression. Trusted by entrepreneurs, investors, and corporations worldwide, Occam Global is recognized as the premier partner for executive search and recruitment in the life sciences. Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.